Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis

To compare clinical curative effects and toxicity of recombinant human adenovirus-p53 injection (rAd-p53, Gendicine) combining chemoradiotherapy (CRT)/radiotherapy (RT) with those obtained with CRT/RT alone in nasopharyngeal carcinoma (NPC). We searched all the eligible studies from the Pubmed, Coch...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Cheng, Xu, Xin-Hua, Chen, Zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083707/
https://www.ncbi.nlm.nih.gov/pubmed/27843742
http://dx.doi.org/10.1186/s40064-016-3574-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083707/
https://www.ncbi.nlm.nih.gov/pubmed/27843742
http://dx.doi.org/10.1186/s40064-016-3574-6

Ejemplares similares